First Trust Advisors
IMGN

First Trust Advisors’s Immunogen Inc IMGN Stock Holding History

First Trust Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-307,539
Closed -$9.12M – 2442
2023
Q4 		$9.12M Buy
+307,539
New +$6.12M 0.01% 1031
2021
Q4 		– Sell
-77,992
Closed -$442K – 2619
2021
Q3 		$442K Sell
77,992
-508,123
-87% -$2.94M ﹤0.01% 2316
2021
Q2 		$3.86M Buy
+586,115
New +$4.09M ﹤0.01% 1507
2018
Q4 		– Sell
-285,406
Closed -$2.7M – 2499
2018
Q3 		$2.7M Sell
285,406
-84,122
-23% -$809K 0.01% 1492
2018
Q2 		$3.6M Buy
+369,528
New +$3.9M 0.01% 1279
2014
Q4 		– Sell
-5,811,998
Closed -$61.5M – 2322
2014
Q3 		$61.5M Buy
5,811,998
+1,690,268
+41% +$19.1M 0.24% 78
2014
Q2 		$48.8M Buy
4,121,730
+512,812
+14% +$6.44M 0.2% 93
2014
Q1 		$53.9M Buy
3,608,918
+1,013,970
+39% +$16M 0.24% 66
2013
Q4 		$38.1M Buy
2,594,948
+465,028
+22% +$7.15M 0.18% 105
2013
Q3 		$36.3M Buy
2,129,920
+493,972
+30% +$8.68M 0.2% 97
2013
Q2 		$27.1M Buy
+1,635,948
New +$26.5M 0.18% 129

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

First Trust Advisors's IMGN Position: Q1 2024 in Review

First Trust Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 307,539 shares — an estimated $9.12M sold.

First Trust Advisors first reported a position in IMGN in Q2 2013 and held it in 11 quarters. The position peaked at $61.5M in Q3 2014. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • First Trust Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • First Trust Advisors sold 307,539 Immunogen Inc shares in Q1 2024, an estimated $9.12M.
  • First Trust Advisors first reported a position in Immunogen Inc in Q2 2013 and held it in 11 quarters.
  • First Trust Advisors's Immunogen Inc position peaked at $61.5M in Q3 2014.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on First Trust Advisors's 13F filing for Q1 2024, filed 13 May 2024.